☰
×
News
Top 20
Insights
Insights+
ThoughtSpot
Interviews
Viewpoints
Exclusive
Spotlight
Events
Magazine
Bespoke
Newswire
x
Search
Search here
Search here
Subscribe Now
Viltepso
NS Phrama's Viltepso (viltolarsen) Receives the US FDA's Approval for Patients with Duchenne Muscular Dystrophy Amenable to Exon 5...
August 12, 2020
Load more...
Back to Home
Modal title
×
Modal body text goes here.